Piper Jaffray Gives Inogen (INGN) Higher Rating; 3 Analysts Covering Omega Healthcare Investors, Inc. (OHI)

February 20, 2018 - By Michael Collier

Among 10 analysts covering Omega Healthcare Investors (NYSE:OHI), 3 have Buy rating, 2 Sell and 5 Hold. Therefore 30% are positive. Omega Healthcare Investors had 27 analyst reports since July 21, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated Omega Healthcare Investors, Inc. (NYSE:OHI) rating on Wednesday, December 20. Cantor Fitzgerald has “Buy” rating and $34.0 target. On Thursday, February 25 the stock rating was upgraded by Jefferies to “Buy”. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) has “Hold” rating given on Monday, June 12 by Jefferies. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) has “Hold” rating given on Thursday, August 3 by Jefferies. As per Wednesday, November 4, the company rating was upgraded by Hilliard Lyons. Jefferies downgraded the stock to “Hold” rating in Tuesday, February 21 report. Stifel Nicolaus downgraded the stock to “Hold” rating in Tuesday, October 31 report. On Tuesday, January 12 the stock rating was downgraded by Jefferies to “Hold”. As per Monday, June 26, the company rating was maintained by Jefferies. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) has “Buy” rating given on Tuesday, February 13 by Cantor Fitzgerald. See Omega Healthcare Investors, Inc. (NYSE:OHI) latest ratings:

14/02/2018 Broker: SunTrust Rating: Hold New Target: $26.0 Maintain
15/02/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Outperform Upgrade
14/02/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $27.0 Maintain
13/02/2018 Broker: Jefferies Rating: Sell New Target: $21.0 Maintain
13/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $34.0 Maintain
22/01/2018 Broker: SunTrust Rating: Hold New Target: $28.0 Maintain
21/12/2017 Broker: Jefferies Rating: Sell Downgrade
20/12/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $34.0 Initiate
31/10/2017 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold Downgrade
23/10/2017 Broker: Capital One Rating: Equal-Weight New Target: $34 Initiates Coverage On

Among 6 analysts covering Inogen (NASDAQ:INGN), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Inogen has $125.0 highest and $48 lowest target. $93.33’s average target is -25.01% below currents $124.46 stock price. Inogen had 15 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Inogen, Inc. (NASDAQ:INGN) has “Buy” rating given on Wednesday, November 8 by Needham. The stock has “Buy” rating by Needham on Wednesday, August 30. JP Morgan initiated the stock with “Overweight” rating in Wednesday, July 13 report. Piper Jaffray maintained the stock with “Hold” rating in Monday, September 11 report. The stock of Inogen, Inc. (NASDAQ:INGN) has “Strong Buy” rating given on Wednesday, November 11 by Needham. The stock of Inogen, Inc. (NASDAQ:INGN) earned “Buy” rating by Leerink Swann on Wednesday, November 8. Needham maintained the shares of INGN in report on Friday, August 4 with “Buy” rating. Stifel Nicolaus maintained the shares of INGN in report on Tuesday, September 22 with “Buy” rating. The rating was maintained by Piper Jaffray with “Hold” on Friday, August 4. The stock of Inogen, Inc. (NASDAQ:INGN) earned “Neutral” rating by Piper Jaffray on Thursday, March 24.

Investors sentiment decreased to 1.2 in 2017 Q3. Its down 0.31, from 1.51 in 2017Q2. It turned negative, as 14 investors sold Inogen, Inc. shares while 65 reduced holdings. 37 funds opened positions while 58 raised stakes. 20.61 million shares or 0.71% less from 20.76 million shares in 2017Q2 were reported. Waddell & Reed Financial owns 362,200 shares for 0.08% of their portfolio. Peak6 Invs Lp has invested 0% in Inogen, Inc. (NASDAQ:INGN). Envestnet Asset Management reported 0% stake. Yorktown Mngmt And Rech Incorporated holds 0.1% or 4,050 shares. Legal General Grp Incorporated Public Limited reported 33,188 shares. 635 were accumulated by Ls Investment Advsr Limited Com. Pnc Services Group Inc Inc reported 727 shares. Congress Asset Management Ma holds 0.06% of its portfolio in Inogen, Inc. (NASDAQ:INGN) for 43,998 shares. Us Retail Bank De reported 623 shares. Citadel Advsrs Limited Liability has invested 0% of its portfolio in Inogen, Inc. (NASDAQ:INGN). Partner Fund Mngmt Limited Partnership has invested 0.45% in Inogen, Inc. (NASDAQ:INGN). Next Century Growth Investors Ltd accumulated 0.64% or 56,180 shares. Dimensional Fund Advisors Limited Partnership, Texas-based fund reported 517,022 shares. Spectrum Mgmt owns 2 shares. Teachers Retirement System Of The State Of Kentucky invested in 0.01% or 5,700 shares.

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $2.60 billion. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 101.1 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

The stock increased 2.97% or $3.59 during the last trading session, reaching $124.46. About 151,752 shares traded or 16.84% up from the average. Inogen, Inc. (NASDAQ:INGN) has risen 88.09% since February 20, 2017 and is uptrending. It has outperformed by 71.39% the S&P500.

Analysts await Inogen, Inc. (NASDAQ:INGN) to report earnings on February, 27. They expect $0.21 EPS, down 16.00% or $0.04 from last year’s $0.25 per share. INGN’s profit will be $4.38M for 148.17 P/E if the $0.21 EPS becomes a reality. After $0.33 actual EPS reported by Inogen, Inc. for the previous quarter, Wall Street now forecasts -36.36% negative EPS growth.

The stock increased 3.40% or $0.88 during the last trading session, reaching $26.74. About 2.76 million shares traded or 5.77% up from the average. Omega Healthcare Investors, Inc. (NYSE:OHI) has risen 8.55% since February 20, 2017 and is uptrending. It has underperformed by 8.15% the S&P500.

Investors sentiment increased to 1.42 in 2017 Q3. Its up 0.03, from 1.39 in 2017Q2. It is positive, as 35 investors sold Omega Healthcare Investors, Inc. shares while 93 reduced holdings. 37 funds opened positions while 145 raised stakes. 132.55 million shares or 6.11% less from 141.18 million shares in 2017Q2 were reported. Neuberger Berman Group Ltd Liability Co invested in 0.02% or 401,863 shares. Rafferty Asset Mngmt Ltd Liability Corp has 32,483 shares for 0.02% of their portfolio. Huntington Bank reported 0% stake. Panagora Asset Management reported 0% in Omega Healthcare Investors, Inc. (NYSE:OHI). Toronto Dominion Financial Bank has 0% invested in Omega Healthcare Investors, Inc. (NYSE:OHI) for 90 shares. Profund Lc has 0.04% invested in Omega Healthcare Investors, Inc. (NYSE:OHI). 296,164 are held by Manufacturers Life Insurance The. 481,870 are held by New York State Common Retirement Fund. Connecticut-based Greenwich Invest has invested 4.57% in Omega Healthcare Investors, Inc. (NYSE:OHI). 111,805 are held by Arizona State Retirement Sys. Exane Derivatives has 268 shares for 0% of their portfolio. Delphi Mgmt Ma owns 59,111 shares. State Board Of Administration Of Florida Retirement reported 238,119 shares. 172,884 were accumulated by Teacher Retirement System Of Texas. Dimensional Fund Advisors Lp holds 2.82M shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>